1Paschke R,Kist A,Janicke R,et al.Lack of intrathyrcidal tumor necrosis factor a in Graves' disease.J Clin Endoctinol Metab,1992,76 (1):97.
2Kung AW,Jones BM,Lau KS.Interferon-γ inhibits thyrotropin induced thyroglobulin 8one transcription in culured human thyrocytes.J Clin Endocrinol Metab,1990,70(8) ;1512.
3Marazuela M,Garcia Buey L,Gonzalez FB,et al.Thyroid autoimmuene disorders in patients with chtonic hepatitis C before and during interferen-α therapy.C1in Encocrinol,1996,44(3):653.
4Wiji NI,Harst DVD,Bind A,et al.Hypothroidism during immunotherapy with interleukin-α is associated with antithyroid antibodies and response to treatment.J Clin Oneology,1993,11(6):1376.
5Corrales JJ,Offao A,Lopez A,et al.Analysis of IL-2 and IL-6 binding to peripheral blood lymphocytes in Graves' disoaso:relationship with to disease activity.Cytometry,1997,30(2):118.
7Bartalena L,Bogazzi F,Brogioni S,et al.Role of cytokines in the pathogenesis of the euthyroid sick syndrome.Eur J Endocrinol,1998,138 (6):603.
8Bartalena L,Brogionis,Grasso L,et al.Interleukin-6 and the thyroid.Eur J Endoerino1,1995,132(4):386.
9Kocijan T,Wraber B,Bepnik U,et al.Changes in Th1/Th2 cytokine balance in Graves' disease.Pflugers-Arch,2000,440(5):94.
10Kallmann BA,Huther M,Tubes M,et al.Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.Diabetes,1997 Feb,46(2):237.
7Prior JC. Perimenopause, the complex endocrinology of the me- no-pausal transition[ J]. Endocr Rev, 1988,19 (4) : 397-428.
8Shah M, Edman MC, Snkmlth R, Shi P. A rapamycin-binding pro- rein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of SjSgren' s syndrome [ J ]. J Control Release, 2013,1 3 ( 3 ) : 259- 279.
9Ohta M, Moriyama M, Goto Y, Kawano S, Tanaka A, Maehara T, et al. A case of marginal zone B cell lymphoma mimicking IgG4- related dacryoadenitis and sialoadenitis[ J]. World J Surg Onol, 2015,13 ( 1 ) :459.
10Coupland SE. Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines [ J ]. Ophthalmologe, 2004,101 (2) :197-215.
